News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Zacharoula Sidiropoulou: From Zagreb’s Improving Cancer Outcomes and Leadership Course to Lisbon´s INTERACT100
Zacharoula Sidiropoulou/LinkedIn
May 12, 2025, 10:14

Zacharoula Sidiropoulou: From Zagreb’s Improving Cancer Outcomes and Leadership Course to Lisbon´s INTERACT100

Zacharoula Sidiropoulou, Senior Consultant Breast Surgical Oncologist at Hospital São Francisco Xavier, shared a post on LinkedIn:

“From Zagreb’s Improving Cancer Outcomes and Leadership Course to Lisbon´s INTERACT100.
2500 km distance but close enough to get the main lesson:
The strongest connections in life should make us both braver and wiser—brave enough to take risks and wise enough to learn from each other. That’s the beautiful alchemy of deep friendship and continuous growth—each strengthens the other in an upward spiral of possibility.”

Zacharoula Sidiropoulou

More posts featuring Improving Cancer Outcomes and Leadership Course 

cancer INTERACT100 OncoDaily Oncology Zacharoula Sidiropoulou
Special Coverage
Insight
Sep 5, 2025, 12:31
Courtney Jones: A New Publication From the Lab in Blood
Voices
Sep 5, 2025, 12:12
Jennifer Sullivan: Bringing "The Best of What We Are Wherever You Are"
Voices
Sep 5, 2025, 12:06
Armando Orlandi: Extraordinary Success for the 17th Breast Club!
Voices
Sep 5, 2025, 11:58
Roupen Odabashian: How WorkDone Health Tackles a $125B Healthcare Problem
Insight
Sep 5, 2025, 11:56
Eric Small on FY26 Budget: Saving Research Means Saving Lives
Voices
Sep 5, 2025, 11:45
Annalice Gandini: A Case Report on the Successful Use of Dual EGFR Blockade
Voices
Sep 5, 2025, 11:43
Conquering Underfunded and Rare Cancers Through Research - Conquer Cancer, the ASCO Foundation
Science
Sep 5, 2025, 11:34
Harpreet Singh: FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant NSCLC
Voices
Sep 5, 2025, 11:26
Jia (Jenny) Liu: Excited to Share that NECTA PANNA-COTA Trial Reaches 100 Patients Enrolled
Voices
Sep 5, 2025, 11:25
Ivana Cattaneo: Excited to Lead European Government Affairs at BeOne Medicines
Voices
Sep 5, 2025, 11:18
Zodwa Dlamini: Advancing Brain Cancer Care: Precision, AI Innovation, and African Insights
Voices
Sep 5, 2025, 11:17
Narjust Florez: Women in Thoracic Oncology Event at WCLC